C9orf86 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a full length recombinant C9orf86.
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IF, E |
---|---|
Primary Accession | Q3YEC7 |
Other Accession | BC002945 |
Reactivity | Human |
Host | mouse |
Clonality | Monoclonal |
Isotype | IgG2a kappa |
Clone Names | 2E11-1F10 |
Calculated MW | 79549 Da |
Gene ID | 55684 |
---|---|
Other Names | Rab-like protein 6, GTP-binding protein Parf, Partner of ARF, Rab-like protein 1, RBEL1, RABL6, C9orf86, PARF |
Target/Specificity | C9orf86 (AAH02945, 1 a.a. ~ 477 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | C9orf86 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
References
1.Down-regulation of c9orf86 in human breast cancer cells inhibits cell proliferation, invasion and tumor growth and correlates with survival of breast cancer patients.Li YY, Fu S, Wang XP, Wang HY, Zeng MS, Shao JYPLoS One. 2013 Aug 14;8(8):e71764. doi: 10.1371/journal.pone.0071764.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.